• No se han encontrado resultados

Polimorfismos "Lingo1" rs9652490 y rs11856808 y riesgo para el desarrollo de esclerosis múltiple

N/A
N/A
Info
Descargar
Protected

Academic year: 2020

Share "Polimorfismos "Lingo1" rs9652490 y rs11856808 y riesgo para el desarrollo de esclerosis múltiple"

Copied!
229
0
0

Cargando.... (Ver texto completo ahora)

Descargar ahora ( 229 página )

Texto completo

Loading

Figure

Tabla 1. Esquema diagnóstico de EMRR recogido en los criterios de McDonald y cols
Figura 7. Frecuencia de las variantes alélicas de LINGO1 rs9652490 (A/G). 72% 28% Población global A G 80% 20% Población europea A G 81% 19% Población americana A G 53% 47% Población africana A G 74% 26% Población asiática A G
Figura 8. Frecuencia de las variantes alélicas de LINGO-1 rs11856808 (C/T). 56% 44% Población global C T 63% 37% Población europea C T 60% 40% Población americana C T 38% 62% Población africana C T 61% 39% Población asiática C T
Tabla 6. Composición de la mezcla de la reacción de amplificación (x1: volumen por muestra)
+7

Referencias

Descargar ahora ( PDF - 229 página - 1.66 MB )

Outline

Fisiopatogenia de la EM Metodología del análisis genético de las muestras LINGO1 y EM Polimorfismos LINGO1 rs9652490 y rs11856808 y riesgo para el desarrollo de Limitaciones del estudio

Documento similar

Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer

In the context of academic research, our group devel- oped and sponsored the RAVELLO trial, a phase III, international, double-blind, placebo-controlled, inves- tigator-initiated

No favourable effects of Cr (III) supplementation on lipid metabolism on type 2 Diabetes Mellitus: a meta-analysis of single and doubleblind, randomized, placebo controlled trials.

The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled,

ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria

Here, we report 52-week treatment results from the OC5-DB-02 study, a Phase III, randomized, double-blind study evaluating the efficacy and safety of Oxabact versus placebo

Normative biometry of the fetal brain using magnetic resonance imaging

2D and 3D biometric parameters were mea- sured from slice-to-volume reconstructed images, including 3D measurements of supratentorial brain tissue, lateral ventricles,

Nonetheless,thispainconditionisunder-,over-,ormisdiagnosed[ ].Regardingthe AccordingtotheAmericanCollegeofRheumatology(ACR),fibromyalgia(FM)isachronicconditionassociatedwithwidespreadpain,fatigue,sleepproblemsandten- IsIrritableBowelSyndromeConsideredasCom

Effects of Exergames on Quality of Life, Pain, and Disease Effect in Women with Fibromyalgia: A Randomized Controlled Trial. A Randomized Clinical Trial of an Individualized

TheOncologist 2016;21:701 – 707www.TheOncologist.com InhibitionofPeripheralSynthesisofSerotoninasaNewTargetinNeuroendocrineTumors

The TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome) trial is a randomized, double-blind study with 3 treatment arms:

Brain injury in the international multicenter randomized safeBoosc phase ii feasibility trial: cranial ultrasound and magnetic resonance imaging assessments

It has previously been reported that low cerebral NIRS values in preterm infants during the first days of life are asso- ciated with higher grades of intraventricular hemorrhage and

SocietyforCardiovascularMagneticResonance(SCMR)expertconsensusforCMRimagingendpointsinclinicalresearch:partI-analyticalvalidationandclinicalqualification REVIEWOpenAccess

Analysis of Left Ventricular Volumes and Function: A Multicenter Comparison of Cardiac Magnetic Resonance Imaging, Cine Ventriculography, and Unenhanced and Contrast-Enhanced